SCHEMBL14764207

SCHEMBL14764207

O=c1c(O)c(-c2cccc(O)c2)oc2cc(O)cc(O)c12

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 10/20 0.79
▸ KMT2A Q03164 10/20 0.79
▸ CYP1A2 P05177 9/20 0.79
▸ CYP3A4 P08684 7/20 0.79
▸ CYP2C9 P11712 7/20 0.79
▸ CYP1A1 P04798 7/20 0.79
▸ CYP1B1 Q16678 7/20 0.79
▸ XDH P47989 6/20 0.79
▸ FTO Q9C0B1 6/20 0.79
▸ MAPT P10636 6/20 0.79
▸ ABCB1 P08183 6/20 0.79
▸ CYP2D6 P10635 5/20 0.79
▸ CYP2C19 P33261 5/20 0.79
▸ BCHE P06276 4/20 0.79
▸ ACHE P22303 4/20 0.79
▸ CA12 O43570 4/20 0.79
▸ PPARG P37231 4/20 0.79
▸ CA7 P43166 4/20 0.79
▸ TRPC5 Q9UL62 4/20 0.79
▸ MAOA P21397 4/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30714882 1.00 MEN1 (0.79) MEN1KMT2ACYP1A2CYP3A4CYP2C9
Galangin SCHEMBL117225 0.88 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4CYP2C9
Galangin SCHEMBL29393121 0.88 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4CYP2C9
SCHEMBL28432225 0.86 MEN1 (0.85) MEN1KMT2ACYP1A2CYP3A4CYP2C9
Quercetin SCHEMBL17629824 0.84 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4CYP2C9
Quercetin SCHEMBL31507620 0.84 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4CYP2C9
Quercetin SCHEMBL29351036 0.84 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4CYP2C9
Quercetin SCHEMBL118425 0.84 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4CYP2C9
Quercetin SCHEMBL19723 0.84 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4CYP2C9
Quercetin SCHEMBL29353785 0.84 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024016142-A1 USE OF BERGAPTEN AND QUERCETIN FLAVONE COMPOSITION IN PREPARATION OF MEDICAMENT FOR TREATING CANCER 安徽科技学院 2024-01-25 — — WO disclosed
WO-2013034119-A1 4-METHYLCATECHOL DERIVATIVES UND USE THEREOF Thanares GmbH (DE) 2013-03-14 — — WO disclosed
Send feedback